Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lanting TAO"'
Autor:
Ruifeng Zeng, Fang Lai, Manhua Huang, Decai Zhu, Baijian Chen, Lanting Tao, Wei Huang, Chengzhi Lai, Banghan Ding
Publikováno v:
Pilot and Feasibility Studies, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract Background At present, even the first-line medication epinephrine still shows no evidence of a favourable neurological outcome in patients with sudden cardiac arrest (SCA). The high mortality of patients with postcardiac arrest syndrome (PCA
Externí odkaz:
https://doaj.org/article/83e4bd51a7974d7b821544b741dfba49
Autor:
Wenmin Chen MM, Jietao Lin MD, Ting Yang MM, Ze xin Zhang MM, Lanting Tao MD, Zhiwei Xiao MD, Hanrui Chen MM, Xiangjun Qi MM, Lingling Sun MD, Yang Cao MD, Lizhu Lin MD
Publikováno v:
Integrative Cancer Therapies, Vol 22 (2023)
Background: Anlotinib is used as a third-line treatment for advanced non-small-cell lung cancer (NSCLC), but has limited clinical benefits and several side effects, such as diarrhea and acneiform skin rash. Traditional Chinese Medicine (TCM) is commo
Externí odkaz:
https://doaj.org/article/5fac9f5af8ae43e48f97cfe3991ed37a
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/a40c5e4ef61c489d9f4f67353e0f0270
Autor:
Xiaozhong Liao, Lanting Tao, Wei Guo, Zhuo-Xun Wu, Haiyan Du, Jing Wang, Jue Zhang, Hanrui Chen, Zhe-Sheng Chen, Lizhu Lin, Lingling Sun
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundThe application of apatinib is immensely limited by its acquired drug resistance. This research investigates whether cordycepin, a component from Cordyceps could synergize with apatinib to improve its anticancer effect on non-small cell lun
Externí odkaz:
https://doaj.org/article/b5937ab908014e46a234f259526b4bf6
Autor:
Xiaozhong Liao, Ying Gao, Jiahui Liu, Lanting Tao, Jun Xie, Yueyu Gu, Taoli Liu, Dongmei Wang, Dan Xie, Suilin Mo
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Cisplatin (DDP) represents one of the common drugs used for esophageal squamous cell carcinoma (ESCC), but side effects associated with DDP and drug resistance lead to the failure of treatment. This study aimed to understand whether tanshinone IIA (t
Externí odkaz:
https://doaj.org/article/513a26601c1644c5b403eb90e737a975
Publikováno v:
Minerva Anestesiologica; Nov2024, Vol. 90 Issue 11, p1041-1050, 10p
Autor:
Lanting Tao, Zhaofan Mo, Zunjiang Li, Shuang Li, Ziqing Luo, Dongli Li, Dawei Wang, Wei Zhu, Banghan Ding
Publikováno v:
Phytomedicine. 110:154641
Publikováno v:
In World Science and Technology October 2011 13(5):777-782
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology